Pharma Giant Buys Bankrupt DNA Collection Company, Acquiring Access To Largest Genetic Database On Earth

0
209

American biotechnology firm Regeneron Pharmaceuticals is buying the personal genetics brand 23andMe after submitting a winning bid of $256 million in a bankruptcy auction, according to a Monday company statement.

Regeneron will be acquiring a vast wealth of personal genomic data as part of the purchase. 23andMe‘s proprietary Biobank is by far the largest repository for human genomic data in the world, the company claimed in 2024.

The biobank had stores of genetic data from over 15 million people, over 80 percent of whom consented to have their data used for research purposes as of 2024, according to 23andMe.

“Overall, the combined phenotypic and genetic data available for life sciences research from 23andMe is an order of magnitude larger than any other cohort,” the company claimed.

The 15 million figure likely took a hit when 23andMe filed for chapter 11 bankruptcy in…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here